On Invalid Date, Kronos Bio (NASDAQ: KRON) reported Q4 2023 earnings per share (EPS) of -$0.43, up 23.21% year over year. Total Kronos Bio earnings for the quarter were -$25.32 million. In the same quarter last year, Kronos Bio's earnings per share (EPS) was -$0.56.
As of Q1 2024, Kronos Bio's earnings has grown year over year. Kronos Bio's earnings in the past year totalled -$112.67 million.
What is KRON's earnings date?
Kronos Bio's earnings date is Invalid Date. Add KRON to your watchlist to be reminded of KRON's next earnings announcement.
What was KRON's revenue last quarter?
On Invalid Date, Kronos Bio (NASDAQ: KRON) reported Q4 2023 revenue of $2.29 million up Infinity% year over year. In the same quarter last year, Kronos Bio's revenue was $0.00.
What was KRON's revenue growth in the past year?
As of Q1 2024, Kronos Bio's revenue has grown null year over year. Kronos Bio's revenue in the past year totalled $6.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.